ORONSKY ARNOLD L

Director at DYNAVAX TECHNOLOGIES CORP · on record since Feb 27, 2006
Director at ANESIVA, INC. · on record since Jun 23, 2006
10% owner at ANESIVA, INC. · on record since Jun 23, 2006
Director at METABASIS THERAPEUTICS INC · on record since May 11, 2006
Director at MYOGEN INC · on record since May 5, 2006
10% owner at ReShape Weightloss Inc. · on record since Nov 21, 2007
10% owner at METABASIS THERAPEUTICS INC · on record since Apr 18, 2008
10% owner at TESARO, Inc. · on record since Jun 27, 2012
Director at CORIXA CORP · on record since Jun 1, 2004
Managing Director at Trius Therapeutics Inc · on record since Aug 10, 2010
Director at MACROGENICS INC · on record since Oct 18, 2013
Former 10% Owner at EPOCRATES INC · on record since Feb 7, 2011
10% owner at EPOCRATES INC · on record since Feb 1, 2011
10% owner at Paratek Pharmaceuticals, Inc. · on record since Sep 23, 2011
10% owner at MYOGEN INC · on record since Oct 29, 2003
Director at TESARO, Inc. · on record since Jun 27, 2012
Director at KalVista Pharmaceuticals, Inc. · on record since Nov 28, 2016
10% owner at MACROGENICS INC · on record since Oct 11, 2013
10% owner at · on record since May 22, 2013
Director at · on record since Mar 26, 2014
10% owner at · on record since Mar 26, 2014
10% owner at · on record since Oct 12, 2016
10% owner at · on record since Jun 30, 2015
10% owner at · on record since Oct 6, 2004
10% owner at · on record since Jun 22, 2015
10% owner at · on record since Apr 14, 2015
10% owner at · on record since Oct 17, 2017
10% owner at · on record since Oct 22, 2018
10% owner at · on record since Feb 19, 2019
Director at · on record since Sep 29, 2020
10% owner at · on record since Sep 29, 2020

Insider trading activity of ORONSKY ARNOLD L

Transactions on record: 287; since Nov 6, 2003

Open-market buys: 28; $42M

Open-market sells: 11; $10.9M

Companies traded: 14; last filing Oct 2, 2020

Figures computed from official regulatory filings — .

Companies where ORONSKY ARNOLD L has traded

18 tx · $2M · Oct 2, 2020
6 tx · $1M · Oct 2, 2020
34 tx · $2.4M · May 29, 2020
1 tx · Aug 22, 2019
23 tx · $11.3M · Aug 9, 2018
17 tx · $908.8K · Apr 26, 2017
12 tx · $1M · Mar 3, 2014
12 tx · $7.3M · Feb 18, 2014
1 tx · $1.6M · Sep 23, 2011
5 tx · $9.4M · Aug 10, 2010
42 tx · $6.4M · Jun 24, 2009
13 tx · $8M · May 12, 2008
83 tx · $6M · Nov 21, 2006
20 tx · $13.2M · Jul 14, 2005

Track record of ORONSKY ARNOLD L

Statistical track record

Free account

Open-market buys: 42

Last buy: Sep 25, 2020

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of ORONSKY ARNOLD L

Co-insiders of ORONSKY ARNOLD L

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Buy	55,555	18.00 USD	$1M	conv 46ClusterFirst in 12mo	SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Other	1,620,101	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	OtherD (derivative)	-265,203	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Other	265,203	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	OtherD (derivative)	-1,620,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Oct 2, 2020	AwardD (derivative)	7,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	OtherD (derivative)	-1,040,654	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Other	1,040,654	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Other	3,488,398	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	OtherD (derivative)	-3,488,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	OtherD (derivative)	-3,488,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	OtherD (derivative)	-1,620,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Other	265,203	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	OtherD (derivative)	-1,040,654	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Other	1,620,101	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Buy	55,000	18.00 USD	$990K	conv 46ClusterFirst in 12mo	SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Other	1,040,654	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	OtherD (derivative)	-265,203	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Other	3,488,398	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	May 29, 2020	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Oct 3, 2019	AwardD (derivative)	7,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Venus Concept Inc.Listing unverified	Aug 22, 2019	BuyD (derivative)	0	2,000,000.00 USD	n/a (Converted to USD in the nightly refresh)	Cluster	SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	May 31, 2019	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Oct 5, 2018	AwardD (derivative)	7,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Sep 12, 2018	Buy	58,824	17.00 USD	$1M	conv 23First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Buy	55,555	18.00 USD	$1M	conv 46ClusterFirst in 12mo	SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Other	1,620,101	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	OtherD (derivative)	-265,203	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Other	265,203	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	OtherD (derivative)	-1,620,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Oct 2, 2020	AwardD (derivative)	7,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	OtherD (derivative)	-1,040,654	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Other	1,040,654	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	Other	3,488,398	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Oct 2, 2020	OtherD (derivative)	-3,488,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	OtherD (derivative)	-3,488,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	OtherD (derivative)	-1,620,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Other	265,203	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	OtherD (derivative)	-1,040,654	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Other	1,620,101	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Buy	55,000	18.00 USD	$990K	conv 46ClusterFirst in 12mo	SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Other	1,040,654	—	n/a (No price was disclosed in the filing)		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	OtherD (derivative)	-265,203	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Sep 29, 2020	Other	3,488,398	—	n/a (No price was disclosed in the filing)		SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	May 29, 2020	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Oct 3, 2019	AwardD (derivative)	7,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Venus Concept Inc.Listing unverified	Aug 22, 2019	BuyD (derivative)	0	2,000,000.00 USD	n/a (Converted to USD in the nightly refresh)	Cluster	SEC
DYNAVAX TECHNOLOGIES CORPListing unverified	May 31, 2019	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Oct 5, 2018	AwardD (derivative)	7,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Sep 12, 2018	Buy	58,824	17.00 USD	$1M	conv 23First in 12mo	SEC